This immunophenotypic profile is consistent with a prior clinical study reporting a similarly high frequency of CD34-negative and HLA-DR-negative blast cells, underscoring its significance in the pathophysiology of AML-associated coagulopathy [17]. Here, CD34 is linked to acute myeloid leukemia.